|
SNX30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.098700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.978320E-03 |
| Normal-vs-Stage2 |
6.168400E-02 |
| Normal-vs-Stage3 |
1.581620E-02 |
| Normal-vs-Stage4 |
3.499700E-02 |
| Stage1-vs-Stage2 |
3.551600E-01 |
| Stage1-vs-Stage3 |
9.972200E-01 |
| Stage1-vs-Stage4 |
6.307400E-01 |
| Stage2-vs-Stage3 |
5.187400E-01 |
| Stage2-vs-Stage4 |
3.339800E-01 |
| Stage3-vs-Stage4 |
7.400200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.442100E-04 |
| Normal-vs-AfricanAmerican |
3.818900E-03 |
| Normal-vs-Asian |
6.426100E-02 |
| Caucasian-vs-AfricanAmerican |
8.711600E-01 |
| Caucasian-vs-Asian |
4.642200E-01 |
| AfricanAmerican-vs-Asian |
4.443800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.321500E-03 |
| Normal-vs-Female |
2.072300E-02 |
| Male-vs-Female |
1.151840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.021140E-03 |
| Normal-vs-Extreme_Weight |
3.236900E-04 |
| Normal-vs-Obese |
7.329700E-02 |
| Normal-vs-Extreme_Obese |
8.701700E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.854400E-01 |
| Normal_Weight-vs-Obese |
3.505700E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.497200E-01 |
| Extreme_Weight-vs-Obese |
8.059700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.875600E-01 |
| Obese-vs-Extreme_Obese |
5.272800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.256900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.572140E-02 |
| Normal-vs-Age(61-80Yrs) |
1.160110E-03 |
| Normal-vs-Age(81-100Yrs) |
4.812200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.208300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.533800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.624600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.607900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.796200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.250600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.041000E-03 |
| Normal-VS-Type2 PRCC |
9.244600E-04 |
| Normal-VS-KIRP CIMP |
1.403750E-03 |
| Normal-VS-Unclassified PRCC |
3.343200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.633400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.582200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.373900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.204800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.431500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.642060E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.237200E-03 |
| Normal-vs-N1 |
1.837970E-02 |
| Normal-vs-N2 |
5.704200E-02 |
| N0-vs-N1 |
9.747600E-01 |
| N0-vs-N2 |
2.677200E-01 |
| N1-vs-N2 |
3.291200E-01 |
|
|
